2 results match your criteria: "Q6:05 Astrid Lindgren Children's Hospital[Affiliation]"

Stressors in the daily life of parents after a child's successful cancer treatment.

J Psychosoc Oncol

April 2009

Department of Women and Child Health, Childhood Cancer Research Unit, Q6:05 Astrid Lindgren Children's Hospital, SE-171 76, Stockholm, Sweden.

In previous studies, the report of distress has been documented in parents after successfully completing cancer treatment of a child. It is typically assumed that this distress represents lasting reactions to experiences during active treatment, in the form of post-traumatic stress or less severe crisis reactions. However, some researchers have suggested that parents may also perceive current stressors related to a child's cancer even after successful completion of the cancer treatment.

View Article and Find Full Text PDF

Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.

Oncol Rep

April 2004

Childhood Cancer Research Unit, Q6:05 Astrid Lindgren Children's Hospital, Karolinska Hospital, S-171 76 Stockholm, Sweden.

Neuroblastoma, the most common extracranial solid tumour in children, may undergo spontaneous differentiation or regression, but the majority of metastatic neuroblastomas have poor prognosis despite intensive treatment. Retinoic acid and its analogues regulate growth and differentiation of neuroblastoma cells in vitro, and 13-cis retinoic acid has shown activity against human neuroblastomas in vivo. Fenretinide [N-(4-hydroxyphenyl)retinamide] has been identified as a synthetic retinoid able to induce apoptosis of numerous malignant cell lines in vitro, including neuroblastoma.

View Article and Find Full Text PDF